Zobrazeno 1 - 10
of 28
pro vyhledávání: '"R W Mertens"'
Autor:
Hugo A. Katus, Moritz Biener, M C Arrivas, Nikolaus Marx, Evangelos Giannitsis, Julia Moellmann, M V Rueckbeil, R W Mertens, Florian Kahles, Michael Lehrke
Publikováno v:
European Heart Journal. 42
Background The gut incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide) are secreted by enteroendocrine cells following food intake leading to insulin secretion and glucose lowering. Beyond its regulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac97012663af0d2b3ee5e1c15e3ae9e
https://doi.org/10.1093/eurheartj/ehab724.1139
https://doi.org/10.1093/eurheartj/ehab724.1139
Autor:
R W Mertens, Julia Moellmann, Moritz Biener, M C Arrivas, Hugo A. Katus, Marcia Viviane Rückbeil, Evangelos Giannitsis, Florian Kahles, Michael Lehrke, Nikolaus Marx
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association : JAHA 10(13), e019477 (2021). doi:10.1161/JAHA.120.019477
Journal of the American Heart Association : JAHA 10(13), e019477 (2021). doi:10.1161/JAHA.120.019477
Journal of the American Heart Association : JAHA 10(13), e019477 (2021). doi:10.1161/JAHA.120.019477
Published by Association, New York, NY
Published by Association, New York, NY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b224dbfbc87c2ab46fadc0ba647675
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
Autor:
Evangelos Giannitsis, Marcia Viviane Rückbeil, Mohammad Almalla, Moritz Biener, Nikolaus Marx, J. Schroeder, Julia Moellmann, Florian Kahles, Michael Lehrke, Elias Haj-Yehia, Matthias Rau, R W Mertens, Hugo A. Katus
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 3952, p 3952 (2020)
Journal of Clinical Medicine
Volume 9
Issue 12
Journal of Clinical Medicine
Volume 9
Issue 12
Aims: Recent studies have found circulating concentrations of the gastrointestinal hormone GLP-1 to be an excellent predictor of cardiovascular risk in patients with myocardial infarction. This illustrates a yet not appreciated crosstalk between the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0972db019aeb2ffe87e4853a5cbd793a
https://www.mdpi.com/2077-0383/9/12/3952
https://www.mdpi.com/2077-0383/9/12/3952
Autor:
Moritz Biener, Julia Moellmann, R W Mertens, M C Arrivas, M V Rueckbeil, Evangelos Giannitsis, Hugo A. Katus, Florian Kahles, Michael Lehrke, Corinna Lebherz, Nikolaus Marx
Publikováno v:
European Heart Journal. 41
Background GLP-1 and GLP-2 (glucagon-like peptide-1/2) are gut derived hormones that are co-secreted from intestinal L-cells in response to food intake. While GLP-1 is known to induce postprandial insulin secretion, GLP-2 enhances intestinal nutrient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b34994150a2deb1060a83525459c95f
https://doi.org/10.1093/ehjci/ehaa946.1592
https://doi.org/10.1093/ehjci/ehaa946.1592
Autor:
Florian Kahles, Michael Lehrke, M V Rueckbeil, Evangelos Giannitsis, Julia Moellmann, Nikolaus Marx, R W Mertens, M C Arrivas, M C Biener, Hugo A. Katus, Corinna Lebherz, Ann Christina Foldenauer
Publikováno v:
European Heart Journal. 40
Background Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone, which induces post-prandial glucose-dependent insulin secretion. GLP-1 receptor agonists improve cardiovascular outcomes in patients with diabetes at high cardiovascular risk. We r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f246ba6eb6171161ac6836e134bba6
https://doi.org/10.1093/eurheartj/ehz748.0510
https://doi.org/10.1093/eurheartj/ehz748.0510
Autor:
Hugo A. Katus, Florian Kahles, Michael Lehrke, Moritz Biener, M C Arrivas, Ann Christina Foldenauer, Julia Moellmann, Nikolaus Marx, R W Mertens, Marcia Viviane Rückbeil, Evangelos Giannitsis, Corinna Lebherz
Publikováno v:
European heart journal. 41(7)
Aims Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently found to be increased in patients with acute myocardial infarction. Glucagon-like peptide 1 receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::974c92ceb884b7b4a72926354cf2c793
https://pubmed.ncbi.nlm.nih.gov/31834367
https://pubmed.ncbi.nlm.nih.gov/31834367
Autor:
Nikolaus Marx, Florian Kahles, Michael Lehrke, S. Diebold, I Diepolder, R W Mertens, Corinna Lebherz, C Halim, B Walla, M V Rueckbeil, Ana Liberman, Matthias Rau, Julia Moellmann, Mathias Burgmaier
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb1903596a7c6e96d11947882a77f0d2
https://doi.org/10.1093/eurheartj/ehy563.4147
https://doi.org/10.1093/eurheartj/ehy563.4147
Autor:
Matthias Rau, R W Mertens, Constantin Halim, Florian Kahles, Michael Lehrke, Corinna Lebherz, Julia Möllmann, S. Diebold, Nikolaus Marx, Ana Liberman, Benedikt Walla, Irmgard Diepolder, Marcia Viviane Rückbeil, Mathias Burgmaier
Publikováno v:
Molecular metabolism 14, 150-157 (2018). doi:10.1016/j.molmet.2018.05.014
Molecular Metabolism, Vol 14, Iss, Pp 150-157 (2018)
Molecular Metabolism, Vol 14, Iss, Pp 150-157 (2018)
Objective: The incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide) are secreted by the gut after food intake leading to pancreatic insulin secretion and glucose lowering. Beyond its role in glucose con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c7f7a1d08eabc725c1e34a639a0261
Publikováno v:
Advances in experimental medicine and biology. 499
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa0d939eb5eb0b05b55eebeeb7702123
https://pubmed.ncbi.nlm.nih.gov/11729909
https://pubmed.ncbi.nlm.nih.gov/11729909
Publikováno v:
Jeugd in Ontwikkeling. 2023, p1-23. 23p.